These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30380945)

  • 1. Effects of Repeated Eyelid Injections with Botulinum Toxin A on Innervation of Treated Muscles in Patients with Blepharospasm.
    Olson RM; Mokhtarzadeh A; McLoon LK; Harrison AR
    Curr Eye Res; 2019 Mar; 44(3):257-263. PubMed ID: 30380945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulating neuromuscular junction density changes in botulinum toxin-treated orbicularis oculi muscle.
    Harrison AR; Berbos Z; Zaldivar RA; Anderson BC; Semmer M; Lee MS; McLoon LK
    Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):982-6. PubMed ID: 21087967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of botulinum toxin: an application to blepharospasm Schwartz-Jampel syndrome.
    Vargel I; Canter HI; Topaloglu H; Erk Y
    J Craniofac Surg; 2006 Jul; 17(4):656-60. PubMed ID: 16877909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innervation zone of orbicularis oculi muscle and implications for botulinum A toxin therapy.
    Borodic GE; Cozzolino D; Ferrante R; Wiegner AW; Young RR
    Ophthalmic Plast Reconstr Surg; 1991; 7(1):54-60. PubMed ID: 1708272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
    Cakmur R; Ozturk V; Uzunel F; Donmez B; Idiman F
    J Neurol; 2002 Jan; 249(1):64-8. PubMed ID: 11954870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of upper eyelid myectomy on subsequent chemodenervation in the management of benign essential blepharospasm.
    Kent TL; Petris CK; Holds JB
    Ophthalmic Plast Reconstr Surg; 2015; 31(3):222-6. PubMed ID: 25192329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Botulinum Toxin A Treatment on Eyelid Pressure in Eyes with Blepharospasm.
    Namiguchi K; Mizoue S; Ohta K; Shiraishi A
    Curr Eye Res; 2018 Jul; 43(7):896-901. PubMed ID: 29641935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrical activation of the orbicularis oculi muscle does not increase the effectiveness of botulinum toxin type A in patients with blepharospasm.
    Conte A; Fabbrini G; Belvisi D; Marsili L; Di Stasio F; Berardelli A
    Eur J Neurol; 2010 Mar; 17(3):449-55. PubMed ID: 19968711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eyelid botulinum toxin injections for the dry eye.
    Sahlin S; Linderoth R
    Dev Ophthalmol; 2008; 41():187-192. PubMed ID: 18453769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schwartz-Jampel syndrome: surgical management of the myotonia-induced blepharospasm and acquired ptosis after failure with botulinum toxin A injections.
    Morrison DA; Mellington FB; Hamada S; Moore AT
    Ophthalmic Plast Reconstr Surg; 2006; 22(1):57-9. PubMed ID: 16418670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment Effects of Botulinum Toxin Injection and Acupuncture on Blepharospasm Assessed by the Change in Lower Eyelid Tension.
    Bao FF; Li QS; Zhang ZY; Xiang MH
    Curr Eye Res; 2019 Jun; 44(6):679-683. PubMed ID: 30724635
    [No Abstract]   [Full Text] [Related]  

  • 12. Botulinum-induced alteration of nerve-muscle interactions in the human orbicularis oculi following treatment for blepharospasm.
    Alderson K; Holds JB; Anderson RL
    Neurology; 1991 Nov; 41(11):1800-5. PubMed ID: 1944912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative crossover study on the treatment of hemifacial spasm and blepharospasm: preseptal and pretarsal botulinum toxin injection techniques.
    Lolekha P; Choolam A; Kulkantrakorn K
    Neurol Sci; 2017 Nov; 38(11):2031-2036. PubMed ID: 28884242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurophysiological observations on the effects of botulinum toxin treatment in patients with dystonic blepharospasm.
    Valls-Sole J; Tolosa ES; Ribera G
    J Neurol Neurosurg Psychiatry; 1991 Apr; 54(4):310-3. PubMed ID: 1647444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Videonystagmography as a tool to assess blepharospasm before and after botulinum toxin injection.
    Casse G; Adenis JP; Sauvage JP; Robert PY
    Graefes Arch Clin Exp Ophthalmol; 2008 Sep; 246(9):1307-14. PubMed ID: 18581129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apraxia of eyelid opening: clinical features and therapy.
    Kerty E; Eidal K
    Eur J Ophthalmol; 2006; 16(2):204-8. PubMed ID: 16703535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic features of human orbicularis oculi treated with botulinum A toxin.
    Harris CP; Alderson K; Nebeker J; Holds JB; Anderson RL
    Arch Ophthalmol; 1991 Mar; 109(3):393-5. PubMed ID: 2003801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Riolan's muscle: action and indications for botulinum toxin injection.
    Mackie IA
    Eye (Lond); 2000 Jun; 14 ( Pt 3A)():347-52. PubMed ID: 11026998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Blepharospasm in Schwartz-Jampel Syndrome: Botulinum Toxin A Injection or Surgery.
    Kashkouli MB; Shahrzad S; Jazayeri AA; Abtahi MB
    Ophthalmic Plast Reconstr Surg; 2017; 33(3S Suppl 1):S47-S49. PubMed ID: 26020714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.